Diazepam (DIAZEPAM ORAL)
Diazepam (DIAZEPAM ORAL) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Diazepam; Generic name: DIAZEPAM ORAL; Drug class: Benzodiazepine [EPC].
| Brand name | Diazepam |
|---|---|
| Generic name | DIAZEPAM ORAL |
| Drug class | Benzodiazepine [EPC] |
| Manufacturer | Chartwell Governmental & Specialty RX, LLC. |
| Used for | INDICATIONS Diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), athetosis, and stif |
| Dosage | DOSAGE AND ADMINISTRATION Dosage should be individualized for maximum beneficial effect. While the usual daily dosages given below will meet the needs of most patients, there will be some who may require higher doses. In such cases dosage should be increased cautiously to avoid adverse effects. Adults: Usual Daily Dosage: Management of Anxiety Disorders and Relief of Symptoms of Anxiety. Depending upon severity of symptoms - 2 mg to 10 mg, 2 to 4 times daily. Symptomatic Relief in Acute Alcohol |
| Warnings | WARNINGS Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including diazepam, and opioids may result in profound sedation, respiratory depression, coma, and death. Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioi |
| Active ingredient(s) | DIAZEPAM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=167ee280-be68-4a28-a7d8-de41df14bc48 |